Edition:
United States

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.52USD
3:59pm EST
Change (% chg)

$0.02 (+0.80%)
Prev Close
$2.50
Open
$2.49
Day's High
$2.52
Day's Low
$2.45
Volume
4,118
Avg. Vol
21,914
52-wk High
$7.15
52-wk Low
$2.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.98 34.59
P/E High - Last 5 Yrs. -- 40.44 45.93
P/E Low - Last 5 Yrs. -- 23.35 24.19
Beta 1.45 0.82 0.81
Price to Sales (TTM) 0.21 5.68 8.08
Price to Book (MRQ) -- 4.36 5.24
Price to Tangible Book (MRQ) -- 4.90 6.43
Price to Cash Flow (TTM) -- 22.95 25.98
% Owned Institutions 21.69 1.24 2.27

Dividends

  Company industry sector
Dividend Yield -- 1.60 1.52
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.22 5.21
Payout Ratio(TTM) -- 43.76 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -2.41 8.49 9.76
Sales (TTM) vs TTM 1 Yr. Ago -14.23 6.41 7.61
Sales - 5 Yr. Growth Rate 18.37 9.87 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 112.88 16.81 18.78
EPS (TTM) vs TTM 1 Yr. Ago 46.05 -- --
EPS - 5 Yr. Growth Rate -- 10.44 11.55
Capital Spending - 5 Yr. Growth Rate 41.15 14.57 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.91 2.40 2.42
Current Ratio (MRQ) 0.99 3.34 3.39
LT Debt to Equity (MRQ) -- 9.39 12.18
Total Debt to Equity (MRQ) -- 12.62 15.60
Interest Coverage (TTM) -3.72 44.43 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.18 55.20 54.74
Gross Margin - 5 Yr. Avg. 64.57 52.46 52.50
EBITD Margin (TTM) 6.14 -- --
EBITD - 5 Yr. Avg -0.57 18.43 14.67
Operating Margin (TTM) -69.70 11.85 4.40
Operating Margin - 5 Yr. Avg. -56.18 14.25 9.99
Pre-Tax Margin (TTM) -96.70 12.22 5.14
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.51 10.24
Net Profit Margin (TTM) -97.10 8.65 1.86
Net Profit Margin - 5 Yr. Avg. -65.04 10.86 6.55
Effective Tax Rate (TTM) -- 22.18 21.87
Effective Tax Rate - 5 Yr. Avg. -- 23.50 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 728,108 924,143,029 823,803,020
Net Income/Employee (TTM) -707,000 108,124,219 96,327,335
Receivable Turnover (TTM) 2.89 5.35 5.44
Inventory Turnover (TTM) 4.89 2.62 3.52
Asset Turnover (TTM) 0.44 0.93 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.48 11.21 10.76
Return on Assets - 5 Yr. Avg. -23.23 12.69 12.05
Return on Investment (TTM) -60.69 14.12 13.67
Return on Investment - 5 Yr. Avg. -31.36 16.62 15.78
Return on Equity (TTM) -- 15.72 15.40
Return on Equity - 5 Yr. Avg. -138.91 17.74 17.04
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.69%
# of Holders: 40
Total Shares Held: 2,501,727
3 Mo. Net Change: 87,657
# New Positions: 2
# Closed Positions: 4
# Increased Positions: 7
# Reduced Positions: 11
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.